Report cover image

Automotive Chassis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published May 01, 2024
Length 182 Pages
SKU # FOB18819991

Description

Automotive Chassis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Automotive Chassis Market

The automotive chassis market size was reached at a value USD 147.68 billion in 2023, and the market is now projected to grow from USD 161.66 billion in 2024 to USD 439.69 billion by 2032, exhibiting a CAGR of 13.3% during the forecast period of 2023-2030.

Government-imposed restrictions on outing and social gathering to prevent the virus from spreading and had a negative impact on automotive industry. Lockdown enacted in numerous nations have hindered the manufacturing and caused transportation delays. In addition, worldwide restrictions have caused a halt in economic activities. The decrease in sales of passenger automobiles and commercial vehicles during the pandemic is a significant element influencing this industry hence reducing automotive chassis market growth. The shutdown of OEM manufacturing units has negatively affected manufacturers and the industry as a whole hence hindered automotive chassis market growth.

The demand for chassis material is rising with time, promoting automotive chassis market growth. Companies and organizations are prioritizing the development of innovative material technologies for automotive chassis due to their impact on conventional and electric vehicles carbon footprints creating remarkable opportunities for market expansion.Hybrid systems and composites are being used by the companies that combine multiple materials, including metal and composites which reduces mass and tooling costs, eliminates corrosion, and improves noise, vibration, and harshness.

Additionally, due to increasing carbon emissions the demand for electric vehicles is rising leading market expansion.Government organizations have established several objectives for reducing carbon emissions which will promote sale of electric vehicles. Manufacturers of electric vehicle are committed to provide automobile chassis with cutting-edge design and weight savings which spurred the automotive chassis market growth.

Comprehensive Analysis of Automotive Chassis Market

The medical devices market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed geographical assessment considering the dominant supply and demand forces that impact the automotive management industry. These segmentations are methodically segregated by types of vehicle and by chassis. The types of By Vehicle Type segment include Passenger Cars, Commercial Vehicles, and Electric Vehicles, and By Chassis Type segment include Non-Conventional, Conventional, and Modular.

In the automotive chassis market, Asia Pacific region lead the automotive devices market by benefitting a market size of USD 62.9 billion in 2023 owing to rising demand for chassis material, availability of raw materials and cheap labor.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Schaeffler Technologies AG (Germany), Hyundai Motor Company (South Korea), Aisin Seiki (Japan), Magna International Inc. (Canada), Continental AG (Germany), ZF Friedrichshafen AG (Germany), Tower International (U.S.), Benteler International AG (Germany), CIE Automotive (Spain), REE Automotive, Ltd. (Israel), these market players provide a level-playing competitive landscape.

In April 2023, Magna International has signed a contracted to develop INEOS Automotive's all-new electric SUV, which will its begin production in Graz, Austria, in 2026.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 13.3% from 2024 to 2032

Unit Value (USD Billion) and Volume (Thousand Units)

Segmentation By Vehicle Type

Passenger Cars

Commercial Vehicles

Electric Vehicles

By Chassis Type

Non-Conventional

Conventional

Modular

By Region

North America (By Vehicle Type, By Country)

- U.S. (By Vehicle Type)

- Canada (By Vehicle Type)

- Mexico (By Vehicle Type)

Europe (By Vehicle Type, By Country)

- U.K. (By Vehicle Type)

- Germany (By Vehicle Type)

- France (By Vehicle Type)

- Rest of Europe (By Vehicle Type)

Asia Pacific (By Vehicle Type, By Country)

- China (By Vehicle Type)

- Japan (By Vehicle Type)

- India (By Vehicle Type)

- South Korea (By Vehicle Type)

- Rest of APAC (By Vehicle Type)

Rest of the World (By Vehicle Type, By Chassis Type)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

182 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Key Diseases, by Countries/Region in 2023
4.2. New Product Launches by Key Players
4.3. Recent Industry Developments - Mergers & Acquisitions
4.4. Overview of Healthcare Expenditure by Key Countries
4.5. Technological Advancements, IVD Instruments & Kits
4.6. Impact of COVID-19 on the In-Vitro Diagnostics Market
5. Global In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product Type
5.1.1. Instruments
5.1.2. Reagents & Consumables
5.2. Market Analysis, Insights and Forecast – By Technique
5.2.1. Immunodiagnostics
5.2.2. Clinical Chemistry
5.2.3. Molecular Diagnostics
5.2.4. Hematology
5.2.5. Others
5.3. Market Analysis, Insights and Forecast – By Setting
5.3.1. Laboratories
5.3.2. Point of care
5.4. Market Analysis, Insights and Forecast – By Application
5.4.1. Infectious Diseases
5.4.2. Cardiology
5.4.3. Oncology
5.4.4. Gastroenterology
5.4.5. Others
5.5. Market Analysis, Insights and Forecast – By End User
5.5.1. Clinical Laboratories
5.5.2. Hospitals
5.5.3. Physician Offices
5.5.4. Others
5.6. Market Analysis, Insights and Forecast – By Geography
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product Type
6.1.1. Instruments
6.1.2. Reagents & Consumables
6.2. Market Analysis, Insights and Forecast – By Technique
6.2.1. Immunodiagnostics
6.2.2. Clinical Chemistry
6.2.3. Molecular Diagnostics
6.2.4. Hematology
6.2.5. Others
6.3. Market Analysis, Insights and Forecast – By Setting
6.3.1. Laboratories
6.3.2. Point of care
6.4. Market Analysis, Insights and Forecast – By Application
6.4.1. Infectious Diseases
6.4.2. Cardiology
6.4.3. Oncology
6.4.4. Gastroenterology
6.4.5. Others
6.5. Market Analysis, Insights and Forecast – By End User
6.5.1. Clinical Laboratories
6.5.2. Hospitals
6.5.3. Physician Offices
6.5.4. Others
6.6. Market Analysis, Insights and Forecast – By Country
6.6.1. U.S.
6.6.1.1. By Setting
6.6.2. Canada
6.6.2.1. By Setting
7. Europe In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product Type
7.1.1. Instruments
7.1.2. Reagents & Consumables
7.2. Market Analysis, Insights and Forecast – By Technique
7.2.1. Immunodiagnostics
7.2.2. Clinical Chemistry
7.2.3. Molecular Diagnostics
7.2.4. Hematology
7.2.5. Others
7.3. Market Analysis, Insights and Forecast – By Setting
7.3.1. Laboratories
7.3.2. Point of care
7.4. Market Analysis, Insights and Forecast – By Application
7.4.1. Infectious Diseases
7.4.2. Cardiology
7.4.3. Oncology
7.4.4. Gastroenterology
7.4.5. Others
7.5. Market Analysis, Insights and Forecast – By End User
7.5.1. Clinical Laboratories
7.5.2. Hospitals
7.5.3. Physician Offices
7.5.4. Others
7.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.6.1. Germany
7.6.1.1. By Setting
7.6.2. U.K.
7.6.2.1. By Setting
7.6.3. France
7.6.3.1. By Setting
7.6.4. Italy
7.6.4.1. By Setting
7.6.5. Spain
7.6.5.1. By Setting
7.6.6. Scandinavia
7.6.6.1. By Setting
7.6.7. Rest of Europe
7.6.7.1. By Setting
8. Asia Pacific In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product Type
8.1.1. Instruments
8.1.2. Reagents & Consumables
8.2. Market Analysis, Insights and Forecast – By Technique
8.2.1. Immunodiagnostics
8.2.2. Clinical Chemistry
8.2.3. Molecular Diagnostics
8.2.4. Hematology
8.2.5. Others
8.3. Market Analysis, Insights and Forecast – By Setting
8.3.1. Laboratories
8.3.2. Point of care
8.4. Market Analysis, Insights and Forecast – By Application
8.4.1. Infectious Diseases
8.4.2. Cardiology
8.4.3. Oncology
8.4.4. Gastroenterology
8.4.5. Others
8.5. Market Analysis, Insights and Forecast – By End User
8.5.1. Clinical Laboratories
8.5.2. Hospitals
8.5.3. Physician Offices
8.5.4. Others
8.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.6.1. China
8.6.1.1. By Setting
8.6.2. Japan
8.6.2.1. By Setting
8.6.3. India
8.6.3.1. By Setting
8.6.4. Australia
8.6.4.1. By Setting
8.6.5. Southeast Asia
8.6.5.1. By Setting
8.6.6. Rest of Asia Pacific
8.6.6.1. By Setting
9. Latin America In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product Type
9.1.1. Instruments
9.1.2. Reagents & Consumables
9.2. Market Analysis, Insights and Forecast – By Technique
9.2.1. Immunodiagnostics
9.2.2. Clinical Chemistry
9.2.3. Molecular Diagnostics
9.2.4. Hematology
9.2.5. Others
9.3. Market Analysis, Insights and Forecast – By Setting
9.3.1. Laboratories
9.3.2. Point of care
9.4. Market Analysis, Insights and Forecast – By Application
9.4.1. Infectious Diseases
9.4.2. Cardiology
9.4.3. Oncology
9.4.4. Gastroenterology
9.4.5. Others
9.5. Market Analysis, Insights and Forecast – By End User
9.5.1. Clinical Laboratories
9.5.2. Hospitals
9.5.3. Physician Offices
9.5.4. Others
9.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.6.1. Brazil
9.6.1.1. By Setting
9.6.2. Mexico
9.6.2.1. By Setting
9.6.3. Rest of Latin America
9.6.3.1. By Setting
10. Middle East & Africa In-Vitro Diagnostics Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product Type
10.1.1. Instruments
10.1.2. Reagents & Consumables
10.2. Market Analysis, Insights and Forecast – By Technique
10.2.1. Immunodiagnostics
10.2.2. Clinical Chemistry
10.2.3. Molecular Diagnostics
10.2.4. Hematology
10.2.5. Others
10.3. Market Analysis, Insights and Forecast – By Setting
10.3.1. Laboratories
10.3.2. Point of care
10.4. Market Analysis, Insights and Forecast – By Application
10.4.1. Infectious Diseases
10.4.2. Cardiology
10.4.3. Oncology
10.4.4. Gastroenterology
10.4.5. Others
10.5. Market Analysis, Insights and Forecast – By End User
10.5.1. Clinical Laboratories
10.5.2. Hospitals
10.5.3. Physician Offices
10.5.4. Others
10.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.6.1. GCC
10.6.1.1. By Setting
10.6.2. South Africa
10.6.2.1. By Setting
10.6.3. Rest of Middle East & Africa
10.6.3.1. By Setting
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Profiles of Players Operating in the Market
11.2.1. F. Hoffmann-La Roche Ltd.
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Abbott
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Thermo Fisher Scientific Inc.
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Sysmex Corporation
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Siemens Healthineers AG
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. BD
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Seegene Inc.
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. DiaSorin S.p.A.
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. Quest Diagnostics Incorporated
11.2.9.1. Overview
11.2.9.2. Products & Services
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. Bio-Rad Laboratories, Inc.
11.2.10.1. Overview
11.2.10.2. Products & Services
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us